JPRN-UMIN000050714已完成Unknown
A triple-blind, randomized, parallel-group study of the effect of topical additional dexamethasone of fascia iliaca compartment block (FICB) in proximal femoral fracture surgery - Study of the effects of steroid-added FICB
Shimura Hospital0 个研究点目标入组 120 人开始时间: 2023年4月10日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who cannot complain of pain or patients who cannot administer NSAIDs or acetaminophen 2.Patients who received NSAIDs or acetaminophen within 3 hours before entering the operating room to immediately after surgery 3.Subjects who have diabetes or prone to infections 4.Others who have been determined ineligible by principal investigator or sub-investigator
研究者
相似试验
尚未招募
不适用
A comparative study to know the effect of diclofenac gel (used for pain relief) with diclofenac tablet (used for pain relief) in for breast pain.CTRI/2019/02/017635All India Institute of Medical Sciences Bhubaneswar
进行中（未招募）
不适用
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorAdult Rheumatoid Arthritis (RA)MedDRA version: 13.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2010-023587-40-GRF. Hoffmann-La Roche Ltd.700
已完成
不适用
Rosemary anti-stress main studyhealthy personJPRN-UMIN000047500Clinical Creative Co., Ltd44
撤回
3 期
A randomized, double-blind, parallel-group study of the reduction of signs and symptoms during treatment with tocilizumab versus adalimumab, both in combination with MTX, in patients with moderate to severe active rheumatoid arthritis and an inadequate response to treatment with only one TNF inhibitor.RA1000381610023213rheumatoid arthritisNL-OMON36590Roche Nederland B.V.15
进行中（未招募）
1 期
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorAdult Rheumatoid Arthritis (RA)MedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2010-023587-40-DKF. Hoffmann-La Roche Ltd.700